TRIMU 5
From Wikipedia, the free encyclopedia
| Names | |
|---|---|
| IUPAC name
L-tyrosyl-N-{[(3-methylbutyl)amino]acetyl}-D-alaninamide
|
|
| Other names
(2S)-2-amino-3-(4-hydroxyphenyl)-N-[(2R)-1-{[2-(3-methylbutylamino)acetyl]amino}-1-oxopropan-2-yl]propanamide
|
|
| Identifiers | |
| 90815-77-3 |
|
| ChemSpider | 21106389 |
| Jmol 3D image | Interactive graph |
| PubChem | 5487273 |
|
|
|
|
| Properties | |
| C19H30N4O4 | |
| Molar mass | 378.466 |
|
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
|
|
| Infobox references | |
TRIMU 5 is a selective agonist of the mu opioid receptor type 2.[1]
References[edit]
- ^ Eisenberg RM (1994). "TRIMU-5, a mu 2-opioid receptor agonist, stimulates the hypothalamo-pituitary-adrenal axis". Pharmacol. Biochem. Behav. 47 (4): 943–6. doi:10.1016/0091-3057(94)90300-X. PMID 8029266.
| This drug article relating to the nervous system is a stub. You can help Wikipedia by expanding it. |

